Dow Down0.02% Nasdaq Up0.07%

More On EMS.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Suda Ltd (EMS.AX)

-ASX
0.00 0.00(0.00%) N/A
ProfileGet Profile for:
Suda Ltd
55 Howe Street
Level 1
Osborne Park, WA 6017
Australia - Map
Phone: 61 8 6142 5555
Fax: 61 8 9443 8858
Website: http://www.sudaltd.com.au

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:27

Business Summary 

Suda Limited engages in the pharmaceutical development of drug delivery technologies in Australia. The company is developing ArTiMist malaria, a sub-lingual spray that has completed Phase III clinical trial for the treatment of p. falciparum severe paediatric malaria. Its product candidates also include SUD-001, a honey-flavoured oral spray formulation of sumatriptan; SUD-002, a mint-flavoured oral spray formulation of ondansetron to treat nausea and vomiting induced by chemotherapy or radiotherapy, and other post-operative settings; and SUD-003, an oral spray formulation of sildenafil sprayed directly in the mouth over the tongue for the treatment of erectile dysfunction. In addition, the company is developing SUD-004, an oral spray formulation of sildenafil to treat pulmonary arterial hypertension in adults; and SUD-005, a strawberry/mint-flavoured oral spray formulation of midazolam for the treatment of pre-procedure anxiety in imaging and dental procedures, and in the treatment of epileptic seizures. Further, it distributes medical devices and consumables to hospitals, aged care facilities, pharmacies, mining companies, and other healthcare providers. The company was formerly known as Eastland Medical Systems Limited and changed its name to Suda Limited in December 2012. Suda Limited is based in Osborne Park, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Suda Ltd

Key Executives 
 PayExercised
Mr. Stephen Carter ,
Managing Director, Chief Exec. Officer, Exec. Director, Member of Audit & Risk Committee and Member of Remuneration Committee
260.00KN/A
Mr. Joseph Ohayon ACA, MBA Intl Bus.,
Chief Financial Officer, Company Sec., Exec. Director, Member of Audit & Risk Committee and Member of Remuneration Committee
211.00KN/A
Mr. Nicholas Woolf MA (OXOM), FCCA, 46
Chief Bus. Officer
126.00KN/A
Mr. John Billingham ,
Gen. Mang. of Westcoast
146.00KN/A
Gail Genero ,
Office Mang.
N/AN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in .